Association Between Copayment and Adherence to Medications for Pulmonary Arterial Hypertension

Association Between Copayment and Adherence to Medications for Pulmonary Arterial Hypertension

Background Pharmacologic treatment for pulmonary arterial hypertension (PAH) improves exercise capacity, functional class, and hemodynamic indexes. However, monthly prescription costs often exceed $4000. We examined associations between (1) medication copayment and (2) annual household income with a...

Full description

Bibliographic Details
Main Authors: Erin M. Schikowski, Gretchen Swabe, Stephen Y. Chan, Jared W. Magnani
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
medication adherence
phosphodiesterase 5 inhibitors
pulmonary arterial hypertension
receptors, epoprostenol
riociguat
soluble guanylyl cyclase
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.026620

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.026620

Similar Items